research

Company profile: Evidera

https://deep-dive.pharmaphorum.com/magazine/disruptive-technologies/data-disruption-and-applying-enabled-intelligence/

What will a no-deal Brexit mean for pharma and healthcare?

https://pharmaphorum.com/views-and-analysis/what-will-a-no-deal-brexit-mean-for-pharma-and-healthcare/

Opening doors in pharmaceutical development

https://deep-dive.pharmaphorum.com/magazine/disruptive-technologies/machine-learning-opening-doors-in-pharmaceutical-development/

Bioprinting organs and the future of healthcare

https://pharmaphorum.com/views-and-analysis/bioprinting-organs-and-the-future-of-healthcare/

New report: Are clinical trials under threat from ‘system overload’?

https://pharmaphorum.com/debates-insight-market-access/new-report-clinical-trials-threat-system-overload/

Web and mobile technologies for health economics modelling

https://pharmaphorum.com/views-and-analysis/web-mobile-technologies-health-economics-modelling/

Patient-centric trials – dream or reality?

https://pharmaphorum.com/views-and-analysis/patient-centric-trials-dream-reality/

Collaboration the key to success in respiratory research

https://pharmaphorum.com/views-and-analysis/collaboration-key-success-respiratory-research/

Access and elimination: the future of DAAs in hepatitis C

https://pharmaphorum.com/views-and-analysis/access-elimination-future-daas-hepatitis-c/

1 2

Close in 10 seconds

Pharmaphorum.com

Search